Sign in
4

Changes in Ownership

CUMBERLAND PHARMACEUTICALS INC Filed Acc 0001209191-21-051441

Director bought 2,414 shares at an average $3.32 ($8,005)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Galante Joseph C Director 2021-07-08 Purchase +142 $3.18 $452 32,559 D
Galante Joseph C Director 2021-07-09 Purchase +142 $3.13 $444 32,701 D
Galante Joseph C Director 2021-07-12 Purchase +142 $3.33 $473 32,843 D
Galante Joseph C Director 2021-07-13 Purchase +142 $3.48 $494 32,985 D
Galante Joseph C Director 2021-07-14 Purchase +142 $3.33 $473 33,127 D
Galante Joseph C Director 2021-07-15 Purchase +142 $3.27 $464 33,269 D
Galante Joseph C Director 2021-07-16 Purchase +142 $3.28 $466 33,411 D
Galante Joseph C Director 2021-07-19 Purchase +142 $3.23 $459 33,553 D
Galante Joseph C Director 2021-07-20 Purchase +142 $3.24 $460 33,695 D
Galante Joseph C Director 2021-07-21 Purchase +142 $3.26 $463 33,837 D
Galante Joseph C Director 2021-07-22 Purchase +142 $3.36 $477 33,979 D
Galante Joseph C Director 2021-07-23 Purchase +142 $3.35 $476 34,121 D
Galante Joseph C Director 2021-07-26 Purchase +142 $3.39 $481 34,263 D
Galante Joseph C Director 2021-07-27 Purchase +142 $3.39 $481 34,405 D
Galante Joseph C Director 2021-07-28 Purchase +142 $3.42 $486 34,547 D
Galante Joseph C Director 2021-07-29 Purchase +142 $3.42 $486 34,689 D
Galante Joseph C Director 2021-07-30 Purchase +142 $3.31 $470 34,831 D
Open-market purchases · 2,414 sh · avg $3.32 · $8,005
Loading xslF345X03/doc4.xml…